ConsumerLab.com uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.

About ConsumerLab.com

Posted October 7, 2017

Weight Loss Supplement Recalled

On October 5, 2017, Kiriko, LLC recalled recalled all lots of A1 Slim 30 capsules after FDA analysis found the products to contain sibutramine, phenolphthalein and N-Desmethyl sibutramine.

Sibutramine, the active ingredient in the obesity drug Meridia, was removed from the U.S. market in October 2010 because it can substantially increase blood pressure and pulse rate in some individuals, and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This drug may also interact, in life-threatening ways, with other medications a consumer may be taking. N-Desmethyl sibutramine is similar to sibutramine.

Phenolphthalein, once an ingredient in some over-the-counter laxative products, was reclassified by the FDA in 1999 as "not generally recognized as safe and effective."

Recalled A1 Slim 30 is packaged in a white plastic bottle containing 30 capsules with a white screw-on cap, and bears the bar code A105212014. It was distributed nationwide through retail stores in Houston, Texas and by mail-order from December 6, 2016 to May 1, 2017. 

Consumers who have purchased these supplements should discontinue use immediately and contact their healthcare provider if they have experienced any adverse side effects. Consumers and healthcare providers are also encouraged to report any adverse reactions to the FDA's MedWatch Adverse Event Reporting Program.

See Related Warnings:

Four Weight Loss Supplements Found To Contain Drugs

Weight Supplement Recalled

Five Weight Loss Supplements Recalled

Weight Loss Supplement Contains Hidden Drug

To read the full recall, use the link below.